Literature DB >> 32601099

An IL-17F.S65L Knock-In Mouse Reveals Similarities and Differences in IL-17F Function in Oral Candidiasis: A New Tool to Understand IL-17F.

Chunsheng Zhou1, Leticia Monin1, Rachael Gordon2, Felix E Y Aggor1, Rami Bechara1, Tara N Edwards3, Daniel H Kaplan3, Sebastien Gingras2, Sarah L Gaffen4.   

Abstract

Oropharyngeal candidiasis (OPC) is an opportunistic infection of the oral mucosa caused by the commensal fungus Candida albicans IL-17R signaling is essential to prevent OPC in mice and humans, but the individual roles of its ligands, IL-17A, IL-17F, and IL-17AF, are less clear. A homozygous IL-17F deficiency in mice does not cause OPC susceptibility, whereas mice lacking IL-17A are moderately susceptible. In humans, a rare heterozygous mutation in IL-17F (IL-17F.S65L) was identified that causes chronic mucocutaneous candidiasis, suggesting the existence of essential antifungal pathways mediated by IL-17F and/or IL-17AF. To investigate the role of IL-17F and IL-17AF in more detail, we exploited this "experiment of nature" by creating a mouse line bearing the homologous mutation in IL-17F (Ser65Leu) by CRISPR/Cas9. Unlike Il17f-/- mice that are resistant to OPC, Il17fS65L/S65L mice showed increased oral fungal burdens similar to Il17a -/- mice. In contrast to humans, however, disease was only evident in homozygous, not heterozygous, mutant mice. The mutation was linked to modestly impaired CXC chemokine expression and neutrophil recruitment to the infected tongue but not to alterations in oral antimicrobial peptide expression. These findings suggest mechanisms by which the enigmatic cytokine IL-17F contributes to host defense against fungi. Moreover, because these mice do not phenocopy Il17f-/- mice, they may provide a valuable tool to interrogate IL-17F and IL-17AF function in vivo in other settings.
Copyright © 2020 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32601099      PMCID: PMC7369233          DOI: 10.4049/jimmunol.2000394

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  102 in total

1.  The human IL-17F/IL-17A heterodimeric cytokine signals through the IL-17RA/IL-17RC receptor complex.

Authors:  Jill F Wright; Frann Bennett; Bilian Li; Jonathan Brooks; Deborah P Luxenberg; Matthew J Whitters; Kathleen N Tomkinson; Lori J Fitz; Neil M Wolfman; Mary Collins; Kyri Dunussi-Joannopoulos; Moitreyee Chatterjee-Kishore; Beatriz M Carreno
Journal:  J Immunol       Date:  2008-08-15       Impact factor: 5.422

Review 2.  IL-17-Mediated Immunity to the Opportunistic Fungal Pathogen Candida albicans.

Authors:  Heather R Conti; Sarah L Gaffen
Journal:  J Immunol       Date:  2015-08-01       Impact factor: 5.422

Review 3.  Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease.

Authors:  Reiko M Onishi; Sarah L Gaffen
Journal:  Immunology       Date:  2010-03       Impact factor: 7.397

4.  Substitution of methionine 63 or 83 in S100A9 and cysteine 42 in S100A8 abrogate the antifungal activities of S100A8/A9: potential role for oxidative regulation.

Authors:  Herve Y Sroussi; Gerwald A Köhler; Nina Agabian; Dana Villines; Joel M Palefsky
Journal:  FEMS Immunol Med Microbiol       Date:  2008-12-11

5.  Milder clinical hyperimmunoglobulin E syndrome phenotype is associated with partial interleukin-17 deficiency.

Authors:  F L van de Veerdonk; R J Marijnissen; R Marijnissen; L A B Joosten; B J Kullberg; J P H Drenth; M G Netea; J W M van der Meer
Journal:  Clin Exp Immunol       Date:  2009-10-30       Impact factor: 4.330

6.  A novel Th cell epitope of Candida albicans mediates protection from fungal infection.

Authors:  Eva Bär; André Gladiator; Sonia Bastidas; Bernd Roschitzki; Hans Acha-Orbea; Annette Oxenius; Salomé LeibundGut-Landmann
Journal:  J Immunol       Date:  2012-04-23       Impact factor: 5.422

7.  Defective IL-17- and IL-22-dependent mucosal host response to Candida albicans determines susceptibility to oral candidiasis in mice expressing the HIV-1 transgene.

Authors:  Mathieu Goupil; Vincent Cousineau-Côté; Francine Aumont; Serge Sénéchal; Louis Gaboury; Zaher Hanna; Paul Jolicoeur; Louis de Repentigny
Journal:  BMC Immunol       Date:  2014-10-26       Impact factor: 3.615

8.  Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis.

Authors:  Heather R Conti; Fang Shen; Namrata Nayyar; Eileen Stocum; Jianing N Sun; Matthew J Lindemann; Allen W Ho; Justine Hoda Hai; Jeffrey J Yu; Ji Won Jung; Scott G Filler; Patricia Masso-Welch; Mira Edgerton; Sarah L Gaffen
Journal:  J Exp Med       Date:  2009-02-09       Impact factor: 14.307

Review 9.  Candida albicans pathogenicity and epithelial immunity.

Authors:  Julian R Naglik; Jonathan P Richardson; David L Moyes
Journal:  PLoS Pathog       Date:  2014-08-14       Impact factor: 6.823

10.  Oral-resident natural Th17 cells and γδ T cells control opportunistic Candida albicans infections.

Authors:  Heather R Conti; Alanna C Peterson; Lucas Brane; Anna R Huppler; Nydiaris Hernández-Santos; Natasha Whibley; Abhishek V Garg; Michelle R Simpson-Abelson; Gregory A Gibson; Anna J Mamo; Lisa C Osborne; Shrinivas Bishu; Nico Ghilardi; Ulrich Siebenlist; Simon C Watkins; David Artis; Mandy J McGeachy; Sarah L Gaffen
Journal:  J Exp Med       Date:  2014-09-08       Impact factor: 14.307

View more
  5 in total

Review 1.  Infections in the monogenic autoimmune syndrome APECED.

Authors:  Vasileios Oikonomou; Timothy J Break; Sarah L Gaffen; Niki M Moutsopoulos; Michail S Lionakis
Journal:  Curr Opin Immunol       Date:  2021-08-18       Impact factor: 7.268

2.  Epidermal clearance of Candida albicans is mediated by IL-17 but independent of fungal innate immune receptors.

Authors:  Mari T Iwasawa; Hideaki Miyachi; Seiichiro Wakabayashi; Takashi Sugihira; Reika Aoyama; Seitaro Nakagawa; Yuki Katayama; Mitsutoshi Yoneyama; Hiromitsu Hara; Yoichiro Iwakura; Masanori Matsumoto; Naohiro Inohara; Hanako Koguchi-Yoshioka; Manabu Fujimoto; Gabriel Núñez; Hiroyuki Matsue; Yuumi Nakamura; Shinobu Saijo
Journal:  Int Immunol       Date:  2022-07-26       Impact factor: 5.071

3.  Activated CLL cells regulate IL-17F-producing Th17 cells in miR155-dependent and outcome-specific manners.

Authors:  Byeongho Jung; Gerardo Ferrer; Pui Yan Chiu; Rukhsana Aslam; Anita Ng; Florencia Palacios; Michael Wysota; Martina Cardillo; Jonathan E Kolitz; Steven L Allen; Jacqueline C Barrientos; Kanti R Rai; Nicholas Chiorazzi; Barbara Sherry
Journal:  JCI Insight       Date:  2022-06-22

4.  Divergent functions of IL-17-family cytokines in DSS colitis: Insights from a naturally-occurring human mutation in IL-17F.

Authors:  Chunsheng Zhou; Dongwen Wu; Chetan Jawale; Yang Li; Partha S Biswas; Mandy J McGeachy; Sarah L Gaffen
Journal:  Cytokine       Date:  2021-09-26       Impact factor: 3.861

Review 5.  Interleukin-17 family members in health and disease.

Authors:  Soo-Hyun Chung; Xiao-Qi Ye; Yoichiro Iwakura
Journal:  Int Immunol       Date:  2021-11-25       Impact factor: 4.823

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.